Dossier · PII · Dormant
PII · Polaris Inc.
Last analysed ·
Current thesis
Powersports turnaround leg ($52→$75.25 peak) has played out and is rolling over PII hit a fresh 52-wk high then fell to $66.06 (−4% on 2026-06-05), now below consensus PT $68. MATURING, special-sit catalyst spent (Indian sale closed 2026-02-02), no fresh catalyst until the 2026-07-28 Q2 print ~7wks out.
Invalidation trigger
Weekly close below the rising 50-DMA / breakout base (~$58), OR the 2026-07-28 Q2 print cuts FY26 adj-EPS guide below the $1.60 floor, OR Q2 ORV retail turns negative YoY (was +3% in Q1 2026).
Thesis status
Open commitment scored if the trigger above fires How this is scored →Current Thesis
The powersports turnaround leg has run its course and is now mean-reverting. After the special-situation catalyst separating Indian Motorcycle and selling the majority stake to Carolwood LP closed 2026-02-02, and Q1 2026 (reported 2026-04-27) printed the first positive adjusted EPS in a year (+$0.13 vs −$0.90 YoY) on gross margin +422bps, the stock pushed from the March-2026 ~$52 base to a fresh 52-week high of $75.25, then retraced ~12% to $66.06 (2026-06-05, down 4.07% on the day). At $66 it sits below the analyst-PT cluster ($68 consensus; Citi $70, Morgan Stanley $69, Raymond James $73, BofA $74). The binary catalysts are spent; the next one (Q2 print) is ~7 weeks out. This is MATURING, value-trap-shaped (4.12% yield, GAAP losses, −$342M Q1 FCF), and the easy recovery money has been made. A LOW-conviction name pending a clean pullback-to-support setup or a fresh portfolio action not a momentum entry near the top of a faded run.
Bull Case
- Margin inflection dated and real: Q1 2026 (2026-04-27) gross margin +422bps; adj EBITDA nearly doubled to $102.8M (6.2% margin) on mix, net price, and operational gains.
- Adjusted EPS swung positive: +$0.13 in Q1 2026 vs −$0.90 in Q1 2025 the single turnaround datapoint that anchors the bull case.
- Powersports demand holding: segment sales +14% in Q1 2026, led by Ranger and snowmobiles; NA ORV retail +3%; snowmobile retail for the '25-'26 season +25% on early snowfall plus promo.
- Portfolio simplification banked: Indian sale to Carolwood closed 2026-02-02 (~$478M / ~7% of TTM revenue), structurally accretive ~$1.00 adj-EPS and ~$50M adj-EBITDA; sharpens the Off-Road core.
- Q2 guide given 2026-04-27: 5–7% sales growth and adj EPS $0.70–0.80; FY26 reaffirmed at adj sales $7.15–7.30B / adj EPS $1.60–1.70 despite tariff drag.
- Sell-side drifted higher post-print: PTs raised late April (Citi $58→$70, Raymond James $66→$73 Outperform, BofA $70→$74) narrative caught up, which for a momentum book reads as late, not early.
Bear Case
- Still GAAP-loss-making: trailing P/E n/a (unprofitable); the "positive EPS" is adjusted only. Q1 net was a loss.
- Cash burn: Q1 2026 adj FCF −$342.5M (seasonal build, but a deep hole to refill before FCF turns).
- Tariff overhang: ~$215M gross 2026 tariff cost; Section 232 offset a $40M benefit from earlier changes, so net relief is thin and FY guide assumes flat retail the rest of the year.
- Expensive on adjusted earnings: forward P/E 29.93 on the $1.60–1.70 FY26 guide full multiple for a no-growth consumer cyclical.
- High yield is a doubt signal: 4.12% on a discretionary name flags skepticism, not safety; the dividend is not a reason to own a broken setup.
- Sell-side already cooling: Morgan Stanley cut to $69 from $74 (2026-05-19); price now trades below consensus $68. Catalysts behind, next binary 2026-07-28.
Setup & Price Structure
- Price path: $38.42 (52-wk low) → $52.37 (2026-03-20) → ~$64 (2026-05-19) → $75.25 (52-wk high, late May) → $66.06 (2026-06-05, −4.07%). The leg overshot the entire analyst-PT cluster, then rolled over ~12%.
- The −4% session on 2026-06-05 (day's range $65.68–$68.62) shows the breakout shelf failing to hold as support; momentum has flipped from accelerating to fading.
- For a MATURING name the playbook entry is a pullback into rising MA support, not a chase. The relevant test zone is the rising 50-DMA / breakout base near ~$58; a weekly close beneath it breaks the recovery structure entirely.
- At $66 the name is below consensus PT ($68) with a Hold rating and only ~3% implied upside to consensus poor reward into a dead catalyst window.
Catalyst Calendar (next 30 days)
- 2026-06-15: Q2 dividend payment $0.68/share (declared 2026-05-04, record date 2026-06-01 already passed). Income event, not a price catalyst.
- No earnings inside the window (2026-06-07 → 2026-07-07). Empty for 30 days.
- 2026-07-28 (OUTSIDE window, ~51 days out): Q2 2026 earnings the next true binary; Q2 guide is 5–7% sales growth / adj EPS $0.70–0.80. No entry into the print unless the thesis becomes earnings-driven.
What Would Change Our Mind
- A weekly close back below ~$58 (rising 50-DMA / breakout base) confirms the recovery leg is over and flips the structure to a value trap stand aside.
- A second portfolio action (e.g. a Marine/Bennington divestiture or a confirmed activist 13D) would re-rate the special-sits thesis from MATURING back to ACCELERATING and justify a real entry none on file as of 2026-06-07.
- A clean pullback to the 20-EMA/50-DMA that holds with off-road retail still positive YoY would set up a fresh MATURING-name entry on support rather than a chase near the faded high.
- The 2026-07-28 Q2 print is the binary: a FY26 adj-EPS guide cut below the $1.60 floor, or ORV retail turning negative YoY (was +3% in Q1), kills the inflection narrative.
Correlation Notes
- Trades with US discretionary-consumer and big-ticket durables sentiment; rate-sensitive given financed powersports purchases moves with retail-spending and consumer-confidence prints.
- Direct powersports peers: BRP (DOO) and Harley-Davidson (HOG); a BRP retail miss or Harley demand warning would read across to PII's off-road and on-road read.
- Tariff/Section 232 headline risk shared with US-manufacturing industrials; a tariff escalation or relief headline moves the whole group, not just PII.
- Idiosyncratic re-rate driver is the special-situation / divestiture path, which decouples it from the powersports tape only when a fresh portfolio action lands.
Notes
~38–40x-shape on adjusted EPS even before the overshoot; forward P/E 29.93 at $66. Not a cheap turnaround.
Notes
- EARNINGS BLACKOUT: Q2 2026 print 2026-07-28 next true binary; no avoid/entry into print unless thesis is earnings-driven.
- Special-situation catalyst already SPENT: Indian Motorcycle separation + majority sale to Carolwood LP closed 2026-02-02 (~$478M / 7.0% TTM rev; accretive ~$1.00 adj-EPS, ~$50M adj-EBITDA).
- No activist 13D/13D-A on file as of 2026-06-04 the 'activism' theme tag is aspirational; the live angle is restructuring/divestiture, not a confirmed activist.
- Dividend King: $0.68/qtr declared 2026-05-04, payable 2026-06-15, ~4.25% yield do NOT hold for the dividend if the setup breaks.
- MATURING name → per playbook, enter ONLY on pullback to 20-EMA/50-DMA, never at the top of the recovery leg. ~38x forward on adjusted EPS not cheap.
- Watch for a second portfolio action (Marine/Bennington divestiture) as the catalyst that would re-rate the special-sits thesis to ACCELERATING.
- Recovery leg OVERSHOT the analyst-PT cluster to a 52-wk high $75.25 (late May), then retraced ~12% to $66.06 (2026-06-05, −4%). The breakout shelf is failing as support momentum flipped from accelerating to fading.
- Special-situation catalyst SPENT: Indian Motorcycle separation + majority sale to Carolwood LP closed 2026-02-02 (~$478M / ~7% TTM rev; accretive ~$1.00 adj-EPS, ~$50M adj-EBITDA).
- No activist 13D/13D-A on file as of 2026-06-07 the 'activism' theme tag is aspirational; live angle is restructuring/divestiture, not a confirmed activist.
- Q2 guide (given 2026-04-27): 5-7% sales growth, adj EPS $0.70-0.80. FY26 reaffirmed adj sales $7.15-7.30B / adj EPS $1.60-1.70.
- Sell-side PT cluster post-Q1: consensus $68 (Hold), Citi $70, Morgan Stanley $69 (cut from $74 on 2026-05-19), Raymond James $73 (Outperform), BofA $74. Price now BELOW consensus.
- Dividend King: $0.68/qtr, payable 2026-06-15, ~4.12% yield do NOT hold for the dividend if the setup breaks.
- MATURING name → enter ONLY on a pullback to 20-EMA/50-DMA that holds, never chasing the faded high. Forward P/E ~30 not cheap.
- Watch for a second portfolio action (Marine/Bennington divestiture) as the catalyst that would re-rate the special-sits thesis back to ACCELERATING.
- Tariff overhang: ~$215M gross 2026 cost; Section 232 offset the $40M benefit from earlier changes; FY guide assumes flat retail rest of 2026.
Related · shared themes
MRX
Marex Group plc
Roll-up compounder confirmed by a record Q1 (reported 2026-05-06: revenue +48% to $692M, adj PBT +59%), with the 2026-06-01 Levmet bolt-on extending a 5-deal-in-12-months cadence. But price has run +39.9% in 90 days to ~$55.89, now at the $57.43 consensus PT and just under the $58.62 high the re-rating leg is largely spent. Accumulate pullbacks toward the rising 20-EMA rather than chase the 52-week high.
FWRD
Forward Air Corporation
Strategic review ended with NO buyer (confirmed 2026-05-08) Clearlake/Apollo walked and a ~$250M customer (~10% of revenue) is leaving starting 2027. The deal-premium thesis that was the only reason to watch this is dead; PTs slashed to $17-18, stock cratered ~45% to ~$10. Deleveraging-grind, not a momentum setup. Narrative velocity decisively negative.
IHRT
iHeartMedia, Inc.
M&A special-sit the only live leg decayed from "on ice" (NYT, 2026-05-29) to "fizzled out" (thedesk.net, 2026-06-01) over the same station-divestiture/antitrust impasse; the $6.56 deal-spec spike has fully round-tripped to ~$4.40. No accelerating narrative a mid-5x-levered radio name with Adj EBITDA -11.4% YoY. pass until talks revive with actual terms.
ILMN
Illumina, Inc.
Recognition-phase genomics re-rate that already ran ~96% in a year; now fading from a new $177 high to ~$163 while activist director Corvex/Meister dumps ~$107M into strength and price sits ~13% above the $143.83 avg PT. MATURING with first distribution showing a chase at the highs. Cleaner entry is a hold of the ~$150s base or the early-Aug Q2 confirmation.